Home › Acute Myeloid Leukemia › Oregon › Portland
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Portland, OR
Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Portland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Nagre-recruitPhase 1
- OHSU Knight Cancer Institute, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi ang layo
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
- Providence Portland Medical Center, Portland
- Providence Oncology and Hematology Care Clinic Westside, Portland
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
- OHSU Knight Cancer Institute, Portland
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
Nagre-recruitPhase 2
- OHSU Knight Cancer Institute, Portland
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
- Oregon Health & Science University, Portland
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Nagre-recruitPhase 1/2
- Oregon Health and Science University, Portland
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Nagre-recruitPhase 3
- US-Portland OR-OHSU, Portland
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
- Doernbecher Children's Hospital, Portland
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Nagre-recruitPhase 3
- Oregon Health & Science University (OHSU) - Knight Cancer Institute, Portland
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Nagre-recruitPhase 1
- OHSU Knight Cancer Institute, Portland
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Nagre-recruitPhase 2
- OHSU Knight Cancer Institute, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Nagre-recruitPhase 2
- Oregon Health and Science University, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
Nagre-recruitPhase 1
- OHSU Knight Cancer Institute, Portland
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
- Oregon Health and Science University, Portland
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
- Oregon Health & Science University, Portland
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Nagre-recruitPhase 1
- OHSU, Portland
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Oregon Health & Science University, Portland
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Seattle, WA41 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA31 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Washington, DC24 pag-aaral
Iba pang pag-aaral sa Portland
- Non-Small Cell Lung Cancer46 pag-aaral
- Kanser (lahat ng uri)34 pag-aaral
- Kanser sa Suso33 pag-aaral
- Kanser sa Prostate33 pag-aaral
- Metastatic Cancer29 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Kanser sa Baga26 pag-aaral
- Kanser ng Endometrium24 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg19 pag-aaral
- Kanser sa Pancreas19 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.